An outbreak within an outbreak: The impact of Infection Prevention and Control strategies on hospital-acquired infections and the occurrence of multi-drug resistant organisms during the COVID-19 pandemic
DOI:
https://doi.org/10.7196/SAMJ.2023.v113i12.971Keywords:
COVID-19, Infection Prevention and Control, MDR, CRE, HAI, Acinetobacter baumanniiAbstract
Background. The coronavirus disease 2019 (COVID-19) pandemic placed an unprecedented strain on intensive care units (ICUs) in South Africa. Infection prevention and control (IPC) strategies were highlighted to minimise the risk to healthcare workers and for the protection of patients from contracting hospital-acquired infections (HAIs). During the third wave, our institution adopted a shift system to address severe burnout among ICU personnel. We noted an upstroke in the occurrence of HAIs, specifically carbapenem-resistant Enterobacterales (CRE) and multidrug-resistant (MDR) Acinetobacter baumannii.
Objectives. To report these outbreaks, compare the rate of CRE and A. baumannii infections with the first COVID-19 wave and to analyse its impact on patient outcomes.
Method. We retrospectively analysed data from a prospectively collected registry involving all adult patients with severe COVID-19 admitted to the dedicated COVID-19 ICU from May 2021 to September 2021. Information from the admission database, including the patients’ demographics, comorbidities, laboratory results and length of ICU stay were extracted.
Results. Ninety patients were admitted with severe COVID-19 during the third wave. There was an outbreak of both CRE (the majority Klebsiella pneumoniae) and A. baumannii. Furthermore, 18 patients cultured the same CRE organism, and 25 patients cultured the environmental organism A. baumannii. The HAI rate was significantly higher compared with the first wave published data: 59/90 (65.6%) v. 73/363 (20.1%, p<0.01). Patients with any HAI had a longer mean stay in ICU (10.1 days v. 6.7 days (p<0.01) and a higher mortality of 48/59 (81%) v. 19/31 (61%) (p=0.05).
Conclusion. We observed a very significant rise in HAIs in the COVID-19 ICU during the third wave compared with the first, with almost three times as many patients developing HAIs. Unsurprisingly, it was associated with a longer mean stay in ICU and a higher mortality. The outbreak of both CRE and A. baumannii, and the fact that many patients cultured the same CRE organism and A. baumannii, strongly suggests that a critical breakdown in IPC measures had occurred.
References
Parker A, Karamchand S, Schrueder N, Lahri S, Rabie H, Aucamp M. Leadership and early strategic response to the SARS- CoV-2 pandemic at a COVID-19 designated hospital in South Africa. S Afr Med J 2020;110(6):463-465. https://doi.org/10.7196/SAMJ.2020.v110i6.14809
Broadhurst AGB, Botha C, Calligaro G, et al. The optimal management of the patient with COVID-19 pneumonia: HFNC, NIV/CPAP or mechanical ventilation? Afr J Thorac Crit Care Med 2022;28(3):119- 128. https://doi.org/10.7196/AJTCCM.2022.v28i3.241
Dheda K, Charalambous S, Karat AS, et al. A position statement and practical guide to the use of particulate filtering facepiece respirators (N95, FFP2 or equivalent) for South African health workers exposed to respiratory pathogens including Mycobacterium tuberculosis and SARS-CoV-2. Afr J Thorac Crit Care Med 2021;27(4):177-186. https://doi.org/10.7196/AJTCCM.2021.v27i4.173
World Health Organization. Global action plan on antimicrobial resistance. Geneva: WHO, 2015. https://www.who.int/publications/i/item/9789241509763 (accessed 7 June 2023).
Murray CJL, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 2022;399(10325):629-655. https://doi.org/10.1016/s0140-6736(21)02724-0 6. World Health Organization. Global research agenda for antimicrobial resistance in human health. Geneva: WHO, 2023. https://www.who.int/publications/m/item/global-research-
agenda-for-antimicrobial-resistance-in-human-health (accessed 7 June 2023).
Moolla MS, Reddy K, Fwemba I, et al. Bacterial infection, antibiotic use and COVID-19: Lessons from the intensive care unit. S Afr Med J 2021;111(6):575-581. https://doi.org/10.7196/SAMJ.2021.
v111i6.15590
Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: A systematic review and meta-analysis. J Infect 2020;81(2):266-275. https://do.org/10.2139/ssrn.3594598
Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: A living rapid review and meta-analysis. Clin Microbiol Infect 2020;26(12):1622-1629. https://doi.org/10.1016/j.cmi.2020.07.016
Calligaro GL, Lalla U, Audley G, et al. The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study. Lancet eCLin Med 2020;28:100570. https://doi.org/10.1016/j.eclinm.2020.100570
Downloads
Published
License
Copyright (c) 2023 B Mashigo, A Parker, U Lalla, B W Allwood, M S Moolla, T Lovelock, C F N Koegelenberg
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
